Here, we tested our hypothesis that knockdown of HIF-1α by siRNA gene therapy delivered by the attenuated Salmonella Typhi Ty21a is a promising strategy to increase the sensitivity of PCa to DDP from the perspective of targeting cancer-specific metabolism. The gene discussed is HIF1A; the disease is cancer.